Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the opioids market?

The opioids market has grown steadily, expected to increase from $23.54 billion in 2024 to $24.22 billion in 2025, with a CAGR of 2.9%. Factors contributing to this growth include their use in pain management, surgical procedures, palliative care, and regulatory policies.

What will be the opioids market size in the future?

The opioids market is anticipated to see steady growth, reaching $27.62 billion by 2029 with a CAGR of 3.3%. Growth factors include increased demand for non-cancer pain management, regulatory changes, the rise of telemedicine, and chronic pain treatments. Key trends include opioid-sparing strategies, medication-assisted treatments, risk mitigation, and public health initiatives.

Get your opioids market report here!

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

What main drivers are fueling expansion in the opioids market?

Rising healthcare expenditures are anticipated to accelerate the growth of the ophthalmic lasers market. Healthcare spending includes costs related to medical services, public health initiatives, and pharmaceuticals, and is influenced by aging populations, medical advancements, and chronic disease prevalence. Increased healthcare funding supports the adoption of advanced laser technologies for precision eye care. According to Health Affairs, the U.S. national healthcare expenditure is projected to rise from $4,799.3 billion in 2023 to $5,048.8 billion in 2024, marking an increase of $249.5 billion. This rise in healthcare spending is contributing to the expansion of the ophthalmic laser market.

What key areas define the segmentation of the global opioids market?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

Who are the dominant players expanding their reach in the opioids market?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

How are evolving market trends shaping opioids Strategies?

Leading firms in the opioid market are prioritizing the innovation of sophisticated drug solutions to strengthen their market presence. The development of novel drugs can potentially enable the treatment of illnesses, and contribute towards the enhancement of healthcare and scientific comprehension. In May 2023, Braeburn Pharmaceuticals Inc., an American company providing solutions for opioid addiction treatment, announced that the US Food and Drug Administration approved Brixadi (buprenorphine) extended-release injectable for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD). It stands as the first and only weekly and monthly subcutaneous injection for moderate to severe OUD, and the first injectable buprenorphine medication utilizing FluidCrystal Injection Depot Technology. If the prescriptive guidance is properly adhered to, patients taking oral buprenorphine-based medicines can transition to equivalent dosages.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13021

Which regions are emerging as leaders in the opioids market?

North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

E-Pharmacy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/e-pharmacy-global-market-report

Generic Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Pharmaceutical Drug Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: